- ongoing, recruitingTherapeutic use (Phase IV)
COVID-19 vaccine immunological studies in Finland
This study in Finland is looking at how well different COVID-19 vaccines protect people. It's especially interested in how strong our body's defence (antibodies) is six months after two vaccine doses, and how this works against current virus types.
Finland - ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A clinical study of MK-1289 in healthy adult men (MK-1289-001)
This study is looking at a new medicine called MK-1289 in healthy adult men. It's the very first time this medicine is being given to people, and the main goal is to see if it's safe and how the body handles it. It's hoped this medicine might help with COVID-19 someday.
Belgium - authorisedTherapeutic use (Phase IV)
Temporal kinetics of antibody and cellular response markers and relative impact of revaccination in patients recovered from COVID-19 after treatment with monoclonal antibodies
Italy